Who has invested in Denovo Biopharma?

Zhejiang Xianju Pharmaceutical, CICC are named among the investors backing Denovo Biopharma.

Denovo Biopharma Funding: $172M Raised, Series D (2020)

Denovo Biopharma funding overview

Denovo Biopharma is based in San Diego, California. Denovo Biopharma has raised $172M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series D announced in December 2020. The round record for Denovo Biopharma runs through 2020; nothing later has been disclosed. Investors on record include Zhejiang Xianju Pharmaceutical, CICC. 2 distinct backers are named across the disclosed rounds.

Denovo Biopharma at a glance

Total raised: $172M
Latest round: Series D
Latest round date: December 2020
Headquarters: San Diego, California
Notable investors: Zhejiang Xianju Pharmaceutical, CICC

Frequently asked about Denovo Biopharma funding

How much has Denovo Biopharma raised?: Denovo Biopharma has raised $172M in total disclosed funding across the rounds on record.
Who has invested in Denovo Biopharma?: Zhejiang Xianju Pharmaceutical, CICC are named among the investors backing Denovo Biopharma.
What was the latest Denovo Biopharma funding round?: The most recent disclosed round is a Series D, announced in December 2020.
Where is Denovo Biopharma based?: Denovo Biopharma is based in San Diego, California.
When did Denovo Biopharma last raise?: The last disclosed Denovo Biopharma round closed in December 2020 at Series D.

Denovo Biopharma totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in San Diego below to benchmark round size and investor mix.

Denovo Biopharma Funding: $172M Raised, Series D (2020)

Denovo Biopharma funding overview

Denovo Biopharma at a glance

Frequently asked about Denovo Biopharma funding

Companies related to Denovo Biopharma (18)

Browse related funding lists (6)